| |
Control Subjects (N = 10) |
CD Medication Naïve (N=10) |
UC Medication Naïve (N=10) |
CD On Steroids (N=3) |
UC On Steroids (N=2) |
| Age in years (mean ± SD) |
13.5 ± 3.9 |
13.4 ± 4.5 |
13.9 ± 4.3 |
15 ± 2 |
16 ± 0.0 |
| Gender M |
3 |
5 |
5 |
2 |
1 |
| F |
7 |
5 |
5 |
1 |
1 |
| Height Z score (mean ± SD) |
-0.4 ± 0.6 |
0.2 ± 1.5 |
-0.4 ± 1.2 |
0.5 ± 1.0 |
-0.7 ± 1.8 |
| BMI Z score (mean ±SD ) |
1.0 ± 0.9 |
0.4 ± 1.3 |
-0.6 ± 0.7 * |
-1.1 ± 2.3 |
-0.2 ± 0.7 |
| Activity index score |
N/A |
37 ± 16 ‡ |
45 ± 17.3 ₠ |
41 ± 1.4 ‡ |
82.5 ± 2.5 ï # |
| TI disease (%) |
N/A |
8 (80%) |
0 (0%) |
3 (100%) |
0 (0%) |
| SC disease (%) |
N/A |
5 (50%) |
3 (30%) |
1 (33%) |
2 (100%) |
N: Number; M: Male; F: Female; SD: Standard Deviation; BMI: Body Mass Index; CD: Crohns Disease; UC: Ulcerative Colitis; TI: Terminal Ileum; SC: Sigmoid Colon
*P value <0.05 when compared to control subjects
ï P value <0.05 when compared to all other groups
‡ Pediatric Crohns Disease Activity Index (PCDAI)
# Pediatric Ulcerative Colitis Activity Index (PUCAI) |
